Matthew Korenberg, PRESIDENT & CHIEF OPERATING at Ligand Pharma, holds 103.86K shares in Ligand Pharma (Ticker: LGND), holds ― shares in Qualigen Therapeutics (Ticker: QLGN).

See the Hottest Stocks Based on Insider Trading >

Matthew Korenberg
Ligand Pharma (LGND)
PRESIDENT & CHIEF OPERATING

Ranked #25,883 out of 98,564 Corporate Insiders

Profitable Transactions

2 out of 3 Profitable Transactions

Average Return

+22.50%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

LGND

0.00%

QLGN

A breakdown of Matthew Korenberg's holdings

See the Top Stocks by Insiders

Insider Roles

Ligand Pharma
(LGND)

PRESIDENT & CHIEF OPERATING

Qualigen Therapeutics
(QLGN)

Director

Roles that Matthew Korenberg holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Ligand Pharma
(LGND)

Rating:Informative Sell

Date:Aug 29, 2018 - Aug 29, 2019

Return:+64.30%

The most profitable trade made by Matthew Korenberg

See the Latest Stocks Traded by Insiders

Matthew Korenberg's Trading History

LGND

Ligand Pharma

Feb 29, 2024

PRESIDENT & CHIEF OPERATING

Uninformative Buy

―

$7.26M

QLGN

Qualigen Therapeutics

―

Director

―

List of latest transactions for each holding click on a transaction to see Matthew Korenberg's performance on stock

See All Insider Trading from Today

Matthew Korenberg insider profile FAQ

What is the percentage of profitable transactions made by Matthew Korenberg?

The percentage of profitable transactions made by Matthew Korenberg is 67%.

What is the average return per transaction made by Matthew Korenberg?

The average return per transaction made by Matthew Korenberg is 22.50%.

What stocks does Matthew Korenberg hold?

Matthew Korenberg holds: LGND, QLGN stocks.

What was Matthew Korenberg’s latest transaction?

Matthew Korenberg latest transaction was an Uninformative Buy of ―.

What was Matthew Korenberg's most profitable transaction?

Matthew Korenberg’s most profitable transaction was an Informative Sell of LGND stock on August 29, 2018. The return on the trade was 64.30%.

What is Matthew Korenberg's role in Ligand Pharma?

Matthew Korenberg's role in Ligand Pharma is PRESIDENT & CHIEF OPERATING.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Matthew Korenberg Insider Profile

Matthew Korenberg Ligand Pharma (LGND)PRESIDENT & CHIEF OPERATING